These companies will do well if they can patent certain strains of cannabis that have potent medical benefits. Much like pharma companies, who sell a treatments for 1000s, 10,000s and 100,000s of $, if a medical cannabis coy can get the right strain then they will be price makers, not takers.
CMY Price at posting:
0.9¢ Sentiment: None Disclosure: Not Held